1887

Journal of Medical Microbiology logo

Volume 72, Issue 8

A meta-analysis of tissue microbial biomarkers for recurrence and metastasis in multiple cancer types No Access

Abstract

Local recurrence and distant metastasis are the main causes of death in patients with cancer. Only considering species abundance changes when identifying markers of recurrence and metastasis in patients hinders finding solutions.

Consideration of microbial abundance changes and microbial interactions facilitates the identification of microbial markers of tumour recurrence and metastasis.

This study aims to simultaneously consider microbial abundance changes and microbial interactions to identify microbial markers of recurrence and metastasis in multiple cancer types.

One thousand one hundred and six non-RM (patients without recurrence and metastasis within 3 years after initial surgery) tissue samples and 912 RM (patients with recurrence or metastasis within 3 years after initial surgery) tissue samples representing 11 cancer types were collected from The Cancer Genome Atlas (TCGA).

Tumour tissue bacterial composition differed significantly among 11 cancers. Among them, the tissue microbiome of four cancers, head and neck squamous cell carcinoma (HNSC), lung squamous cell carcinoma (LUSC), stomach adenocarcinoma (STAD) and uterine corpus endometrial carcinoma (UCEC), showed relatively good performance in predicting recurrence and metastasis in patients, with areas under the receiver operating characteristic curve (AUCs) of 0.78, 0.74, 0.91 and 0.93, respectively. Considering both species abundance changes and microbial interactions for the four cancers, a combination of nine genera (, , , , , , , and ) performed best in predicting patient survival.

Taken together, our results imply that comprehensive consideration of microbial abundance changes and microbial interactions is helpful for mining bacterial markers that carry prognostic information.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): cancer , NetShift , random forest , recurrence and metastasis , survival and tissue microbiome
Funding
This study was supported by the:
  • the National Key R&D Program of China (Award Grant No. 2018YFC0910502)
    • Principle Award Recipient: KangNing
  • the National Natural Science Foundation of China (Award Grant Nos. 32071465, 31871334, and 31671374)
    • Principle Award Recipient: KangNing
© 2023 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001744
2023-08-25
2024-12-03
Loading full text...

Full text loading...

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 2021; 71:209–249 [View Article] [PubMed]
     [Google Scholar]
  2. Mitra A, Mishra L, Li S. EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget 2015; 6:10697–10711 [View Article]
     [Google Scholar]
  3. Liu H, Qiu C, Wang B, Bing P, Tian G et al. Evaluating DNA methylation, gene expression, somatic mutation, and their combinations in inferring tumor tissue-of-origin. Front Cell Dev Biol 2021; 9:619330 [View Article]
     [Google Scholar]
  4. Meng Y, Lu C, Jin M, Xu J, Zeng X et al. A weighted bilinear neural collaborative filtering approach for drug repositioning. Brief Bioinform 2022; 23:bbab581 [View Article] [PubMed]
     [Google Scholar]
  5. Garrett WS. Cancer and the microbiota. Science 2015; 348:80–86 [View Article]
     [Google Scholar]
  6. Yu G, Gail MH, Consonni D, Carugno M, Humphrys M et al. Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features. Genome Biol 2016; 17:163 [View Article] [PubMed]
     [Google Scholar]
  7. Thompson KJ, Ingle JN, Tang X, Chia N, Jeraldo PR et al. A comprehensive analysis of breast cancer microbiota and host gene expression. PLoS One 2017; 12:e0188873 [View Article] [PubMed]
     [Google Scholar]
  8. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22:299–306 [View Article] [PubMed]
     [Google Scholar]
  9. Wong-Rolle A, Wei HK, Zhao C, Jin C. Unexpected guests in the tumor microenvironment: microbiome in cancer. Protein Cell 2021; 12:426–435 [View Article]
     [Google Scholar]
  10. Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y et al. The human tumor microbiome is composed of tumor type–specific intracellular bacteria. Science 2020; 368:973–980 [View Article]
     [Google Scholar]
  11. Fu A, Yao B, Dong T, Chen Y, Yao J et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell 2022; 185:1356–1372 [View Article] [PubMed]
     [Google Scholar]
  12. Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 2017; 358:1443–1448 [View Article] [PubMed]
     [Google Scholar]
  13. Poore GD, Kopylova E, Zhu Q, Carpenter C, Fraraccio S et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature 2020; 579:567–574 [View Article] [PubMed]
     [Google Scholar]
  14. Huang D, Su X, Yuan M, Zhang S, He J et al. The characterization of lung microbiome in lung cancer patients with different clinicopathology. Am J Cancer Res 2019; 9:2047–2063 [PubMed]
     [Google Scholar]
  15. Zhao Z, Fei K, Bai H, Wang Z, Duan J et al. Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer. Thorac Cancer 2021; 12:66–78 [View Article]
     [Google Scholar]
  16. Hosgood HD III, Mongodin EF, Wan Y, Hua X, Rothman N et al. The respiratory tract microbiome and its relationship to lung cancer and environmental exposures found in rural China. Environ Mol Mutagen 2019; 60:617–623 [View Article]
     [Google Scholar]
  17. Tang L, Gu S, Gong Y, Li B, Lu H et al. Clinical significance of the correlation between changes in the major intestinal bacteria species and COVID-19 severity. Engineering 2020; 6:1178–1184 [View Article]
     [Google Scholar]
  18. Lang S, Fairfied B, Gao B, Duan Y, Zhang X et al. Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients. Gut Microbes 2020; 12:1785251 [View Article] [PubMed]
     [Google Scholar]
  19. Haran JP, McCormick BA. Aging, frailty, and the microbiome-how dysbiosis influences human aging and disease. Gastroenterology 2021; 160:507–523 [View Article] [PubMed]
     [Google Scholar]
  20. Metwaly A, Reitmeier S, Haller D. Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders. Nat Rev Gastroenterol Hepatol 2022; 19:383–397 [View Article]
     [Google Scholar]
  21. Choi S-C, Brown J, Gong M, Ge Y, Zadeh M et al. Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice. Sci Transl Med 2020; 12:eaax2220 [View Article] [PubMed]
     [Google Scholar]
  22. Breiman L. Breiman: random forests. Mach Learn 2001; 45:5–32 [View Article]
     [Google Scholar]
  23. Kuntal BK, Chandrakar P, Sadhu S, Mande SS. “NetShift”: a methodology for understanding “driver microbes” from healthy and disease microbiome datasets. ISME J 2019; 13:442–454 [View Article] [PubMed]
     [Google Scholar]
  24. Therneau T. A package for survival analysis. R package 2.37-2; 2012
  25. Seeneevassen L, Bessède E, Mégraud F, Lehours P, Dubus P et al. Gastric cancer: advances in carcinogenesis research and new therapeutic strategies. Int J Mol Sci 2021; 22:3418 [View Article] [PubMed]
     [Google Scholar]
  26. Rizzo AE, Gordon JC, Berard AR, Burgener AD, Avril S. The female reproductive tract microbiome-implications for gynecologic cancers and personalized medicine. J Pers Med 2021; 11:546 [View Article] [PubMed]
     [Google Scholar]
  27. Berben T, Overmars L, Sorokin DY, Muyzer G. Diversity and distribution of sulfur oxidation-related genes in Thioalkalivibrio, a genus of Chemolithoautotrophic and Haloalkaliphilic sulfur-oxidizing bacteria. Front Microbiol 2019; 10:160 [View Article] [PubMed]
     [Google Scholar]
  28. Zhang J, Li X, Han X, Liu R, Fang J. Targeting the thioredoxin system for cancer therapy. Trends Pharmacol Sci 2017; 38:794–808 [View Article] [PubMed]
     [Google Scholar]
  29. Balsera M, Buchanan BB. Evolution of the thioredoxin system as a step enabling adaptation to oxidative stress. Free Radic Biol Med 2019; 140:28–35 [View Article] [PubMed]
     [Google Scholar]
  30. Campillo M, Smith SH, Gally DL, Opriessnig T. Review of methods for the detection of Lawsonia intracellularis infection in pigs. J Vet Diagn Invest 2021; 33:621–631 [View Article] [PubMed]
     [Google Scholar]
  31. Gerth M, Martinez-Montoya H, Ramirez P, Masson F, Griffin JS et al. Rapid molecular evolution of Spiroplasma symbionts of Drosophila. Microb Genom 2021; 7: [View Article]
     [Google Scholar]
  32. Yang J, Hui Y, Zhang Y, Zhang M, Ji B et al. Application of circulating tumor DNA as a biomarker for non-small cell lung cancer. Front Oncol 2021; 11:725938 [View Article]
     [Google Scholar]
  33. Chemi F, Rothwell DG, McGranahan N, Gulati S, Abbosh C et al. Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse. Nat Med 2019; 25:1534–1539 [View Article] [PubMed]
     [Google Scholar]
  34. Chan BA, Hughes BGM. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res 2015; 4:36–54 [View Article] [PubMed]
     [Google Scholar]
  35. He B, Dai C, Lang J, Bing P, Tian G et al. A machine learning framework to trace tumor tissue-of-origin of 13 types of cancer based on DNA somatic mutation. Biochim Biophys Acta Mol Basis Dis 2020; 1866:165916 [View Article] [PubMed]
     [Google Scholar]
  36. Henley SJ, Ward EM, Scott S, Ma J, Anderson RN et al. Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer 2020; 126:2225–2249 [View Article] [PubMed]
     [Google Scholar]
  37. Song Z, Chen X, Shi Y, Huang R, Wang W et al. Evaluating the potential of T cell receptor repertoires in predicting the prognosis of resectable non-small cell lung cancers. Mol Ther Methods Clin Dev 2020; 18:73–83 [View Article] [PubMed]
     [Google Scholar]
  38. Liu J, Lan Y, Tian G, Yang J. A systematic framework for identifying prognostic genes in the tumor microenvironment of colon cancer. Front Oncol 2022; 12:899156 [View Article]
     [Google Scholar]
  39. Liu X, Yuan P, Li R, Zhang D, An J et al. Predicting breast cancer recurrence and metastasis risk by integrating color and texture features of histopathological images and machine learning technologies. Comput Biol Med 2022; 146:105569 [View Article] [PubMed]
     [Google Scholar]
  40. Ye Z, Zhang Y, Liang Y, Lang J, Zhang X et al. Cervical cancer metastasis and recurrence risk prediction based on deep convolutional neural network. CBio 2022; 17:164–173 [View Article]
     [Google Scholar]
  41. Yao Y, Lv Y, Tong L, Liang Y, Xi S et al. ICSDA: a multi-modal deep learning model to predict breast cancer recurrence and metastasis risk by integrating pathological, clinical and gene expression data. Brief Bioinform 2022; 23:bbac448 [View Article] [PubMed]
     [Google Scholar]
  42. Mørup N, Main AM, Jørgensen N, Daugaard G, Juul A et al. The seminal plasma microbiome of men with testicular germ cell tumours described by small RNA sequencing. Andrology 2023; 11:756–769 [View Article] [PubMed]
     [Google Scholar]
  43. Kuugbee ED, Shang X, Gamallat Y, Bamba D, Awadasseid A et al. Structural change in microbiota by a probiotic cocktail enhances the gut barrier and reduces cancer via TLR2 signaling in a rat model of colon cancer. Dig Dis Sci 2016; 61:2908–2920 [View Article] [PubMed]
     [Google Scholar]
  44. Masuzawa T, Shimizu T, Yanagihara Y, Mifuchi I. Macrophage activation and immunostimulating activity of Sphaerotilus natans and its slime fraction. Chem Pharm Bull 1987; 35:2004–2010 [View Article] [PubMed]
     [Google Scholar]
  45. Liu SJ, Dang HX, Lim DA, Feng FY, Maher CA. Long noncoding RNAs in cancer metastasis. Nat Rev Cancer 2021; 21:446–460 [View Article] [PubMed]
     [Google Scholar]
  46. Barrett M, Hand CK, Shanahan F, Murphy T, O’Toole PW. Mutagenesis by microbe: the role of the microbiota in shaping the cancer genome. Trends Cancer 2020; 6:277–287 [View Article] [PubMed]
     [Google Scholar]
  47. Guo S, Chen J, Chen F, Zeng Q, Liu WL et al. Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246/92b-3p/27a-3p and CXCL16. Gut 2020gutjnl-2020-321187 [View Article] [PubMed]
     [Google Scholar]
  48. Apopa PL, Alley L, Penney RB, Arnaoutakis K, Steliga MA et al. PARP1 is up-regulated in non-small cell lung cancer tissues in the presence of the cyanobacterial toxin microcystin. Front Microbiol 2018; 9:1757 [View Article] [PubMed]
     [Google Scholar]
  49. Nishikawa S, Ogawa Y, Eguchi M, Rambukkana A, Shimoji Y. Draft genome sequences of Lawsonia intracellularis swine strains causing proliferative enteropathy in Japan. Microbiol Resour Announc 2018; 7:e01021-18 [View Article] [PubMed]
     [Google Scholar]
  50. Cisak E, Wójcik-Fatla A, Zając V, Sawczyn A, Sroka J et al. Spiroplasma - an emerging arthropod-borne pathogen?. Ann Agric Environ Med 2015; 22:589–593 [View Article] [PubMed]
     [Google Scholar]
  51. Yang M, Yang H, Ji L, Hu X, Tian G et al. A multi-omics machine learning framework in predicting the survival of colorectal cancer patients. Comput Biol Med 2022; 146:105516 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001744
Loading
A meta-analysis of tissue microbial biomarkers for recurrence and metastasis in multiple cancer types
J. Med. Microbiol. 72, 001744 (2023); https://doi.org/10.1099/jmm.0.001744
/content/journal/jmm/10.1099/jmm.0.001744
/content/journal/jmm/10.1099/jmm.0.001744
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL

Supplementary material 2

EXCEL

Supplementary material 3

EXCEL

Supplementary material 4

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error